trending Market Intelligence /marketintelligence/en/news-insights/trending/pilyjaxddt_oxuwzfg3kiq2 content esgSubNav
In This List

RenovaCare appoints board chairman

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


RenovaCare appoints board chairman

RenovaCare Inc. appointed Harmel Rayat, a majority stockholder, as board chairman.

Rayat is an entrepreneur-investor, whose portfolio includes class A commercial properties in the U.S. and Canada. He has invested nearly $6 million in RenovaCare and its stem cell spray technologies.

New York-based RenovaCare is a development-stage company, which focuses on the acquisition, research, development and commercialization of autologous cellular therapies for use in medical and aesthetic applications.